ALEXANDRIA, Va., April 2 -- United States Patent no. 12,264,179, issued on April 1, was assigned to GlaxoSmithKline Biologicals SA (Rixensart, Belgium).
"Epstein-Barr Virus antigen constructs" was invented by Stefania Capone (Rome), Antonella Folgori (Rome), Armin Lahm (Rome) and Benjamin Wizel (Rockville, Md.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides Epstein-Barr Virus antigen polynucleotides, polypeptides and vectors; as well as immunogenic compositions comprising the same. It includes the use of Epstein-Barr Virus antigen constructs to produce vaccines for treating and preventing Epstein-Barr Virus infections and Epstein-Barr Virus-associated diseases, such as multiple sclerosi...